CODE

To drive innovation and support improvements in cancer care, and address information gaps by providing timely information on anti-cancer medicine use back to healthcare systems. It also aims to facilitate new models of access, and to help address the challenges of financial sustainability by providing information on how anti-cancer medicines are actually used in clinical practice

With CODE, participants can look beyond their own patients for collective benefits of gaining insights from the rest of the network. Participants gain the ability to understand drug adoption and implementation, chart the speed and variation of adoption, highlight variations in patients’ access to anti-cancer medicines, provide insights into variations in practice and use of anti-cancer medicines, and create a stimulus for clinical research. Data collection is extracted directly from clinical systems.